The Securities and Exchange Commission (SEC) said Tuesday it launched six new digital platforms and a modern data center as ...

SEC Davao reminds corporations to comply with the 2025 deadlines for online submission of Annual Financial Statements (AFS) ...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus” or the "Company”), today announced that Yuval Cohen, Ph.D., ...

The Company reported a net loss of approximately $17.0 million, or a net loss per basic and diluted share of $1.39, for the ...

Five of the country’s top lawyers are in the running to become the next chairperson of the Securities and Exchange Commission ...

Genmab Announces Financial Results for the First Quarter of 2024May 8, 2025 Copenhagen, Denmark; Interim Report for the First Quarter Ended March 31, 2025HighlightsEPKINLY® (epcoritamab) approved by ...

Securities and Exchange Commission (SEC) chairperson Emilio Aquino is hopeful that his successor will continue the digital ...

During the second half of 2025, Werewolf plans to present interim data from the monotherapy and combination expansion arms, including tolerability, response rate, and durability, and to engage with ...

Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection), has been granted marketing ...

Venezuelan-born co-founder Roger Piñate and his colleague, Jorge Miguel Vasquez, were both charged with making $1-million bribes in the Philippines ... the DOJ and the Securities and Exchange ...

WTX-124 Phase 1/1b clinical trial on track for data readouts and interactions with the FDA in the second half of the year - - First patient dosed in the Phase 1b/2 clinical trial of WTX-330, seeking ...

Good morning, and welcome to the ODP Corporation's First Quarter 2025 Earnings Conference Call. All lines will be on a listen-only mode for today's call, after which instructions will be given to ask ...